Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.
Saved in:
| Title: | Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection. |
|---|---|
| Authors: | Vibholm L; Department of Infectious Diseases, Aarhus University Hospital.; Institute of Clinical Medicine, Aarhus University., Schleimann MH; Department of Infectious Diseases, Aarhus University Hospital.; Institute of Clinical Medicine, Aarhus University., Højen JF; Department of Infectious Diseases, Aarhus University Hospital.; Institute of Clinical Medicine, Aarhus University., Benfield T; Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, and., Offersen R; Department of Infectious Diseases, Aarhus University Hospital.; Institute of Clinical Medicine, Aarhus University., Rasmussen K; Department of Infectious Diseases, Aarhus University Hospital., Olesen R; Department of Infectious Diseases, Aarhus University Hospital., Dige A; Institute of Clinical Medicine, Aarhus University.; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Denmark., Agnholt J; Institute of Clinical Medicine, Aarhus University.; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Denmark., Grau J; Hebron Institute of Research, Department of Infectious Diseases, Barcelona, Spain., Buzon M; Hebron Institute of Research, Department of Infectious Diseases, Barcelona, Spain., Wittig B; Foundation Institute Molecular Biology and Bioinformatics, Freie Universitaet, Berlin, Germany., Lichterfeld M; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Boston; Departments of., Petersen AM; Gastroenterology and.; Microbiology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark., Deng X; Blood Systems Research Institute, San Francisco, California, and.; University of California, San Francisco., Abdel-Mohsen M; Blood Systems Research Institute, San Francisco, California, and.; University of California, San Francisco.; The Wistar Institute, Philadelphia, Pennsylvania; and Departments of., Pillai SK; Blood Systems Research Institute, San Francisco, California, and.; University of California, San Francisco., Rutsaert S; Internal Medicine; and., Trypsteen W; Internal Medicine; and., De Spiegelaere W; Internal Medicine; and.; Morphology, Faculty of Veterinary Medicine, Ghent University, Belgium., Vandekerchove L; Internal Medicine; and., Østergaard L; Department of Infectious Diseases, Aarhus University Hospital.; Institute of Clinical Medicine, Aarhus University., Rasmussen TA; Department of Infectious Diseases, Aarhus University Hospital., Denton PW; Department of Infectious Diseases, Aarhus University Hospital.; Institute of Clinical Medicine, Aarhus University., Tolstrup M; Department of Infectious Diseases, Aarhus University Hospital.; Institute of Clinical Medicine, Aarhus University., Søgaard OS; Department of Infectious Diseases, Aarhus University Hospital.; Institute of Clinical Medicine, Aarhus University. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2017 Jun 15; Vol. 64 (12), pp. 1686-1695. |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
